Global Radiodermatitis Treatment Market 2019-2023 | Increasing Focus on New Product Development to Boost Growth | Technavio
LONDON--(BUSINESS WIRE)--May 15, 2019--
The global radiodermatitis treatment market is expected to post a CAGR of more than 4% during the period 2019-2023, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190515005385/en/
Technavio has published a new market research report on the global radiodermatitis treatment market from 2019-2023. (Graphic: Business Wire)
A key factor driving the growth of the global radiodermatitis treatment market is the rising number of public and private healthcare organizations. To spread awareness about radiodermatitis management and its treatment, many public and private organizations are issuing guidelines to treat this condition efficiently. For instance, the BC Cancer Agency has issued guidelines for the management of radiodermatitis symptoms and recommendations about risk factors associated with the disease. Thus, the growing initiatives by public and private organizations to promote awareness about radiodermatitis diagnosis and treatment will significantly propel the market growth during the forecast period.
As per Technavio, the increasing focus on new product development will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global radiodermatitis treatment market 2019-2023 research report also analyzes other significant trends and market drivers that will affect market growth over 2019-2023.
Global radiodermatitis treatment market: Increasing focus on new product development
Several vendors in the market are increasingly focusing on new product development that involves some advanced concepts and techniques. One of the essential concepts that vendors are focusing on is moisture therapy that involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover. Companies in the radiodermatitis treatment market are also focusing on advanced wound care management techniques such as LLLT therapy or laser therapy to control the symptoms. LLLT has a biostimulating effect and helps in efficient healing by reducing inflammation and preventing fibrosis. Such advances and new product developments will have a significant impact on the market growth during the forecast period.
“Many vendors are striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products to leverage their product portfolio. Moreover, research institutes are also increasing their investments to bring new technologies and drugs that can improve the efficiency of radiodermatitis treatment. Thus, the constant efforts and research initiatives from vendors and researchers will bring new products into the market, which will significantly drive the market growth during the forecast period,” says a research analyst at Technavio.
Global radiodermatitis treatment market: Segmentation analysis
This market research report segments the global radiodermatitis treatment market by product (topical, dressings, and oral), distribution channel (retail pharmacy, online pharmacy, and hospital pharmacy), and geographic regions (Asia, North America, Europe, and ROW).
The Asian region led the market in 2018, followed by North America, Europe, and ROW respectively. The market growth in Asia can be attributed to the rising prevalence of cancer, the increase in mergers and collaborations by key vendors to expand product portfolio, and favorable government initiatives to promote drug development in the region.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Five Forces Analysis
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190515005385/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES ONCOLOGY PHARMACEUTICAL RADIOLOGY
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 05/15/2019 09:40 AM/DISC: 05/15/2019 09:40 AM